Kuros Biosciences AG (SWX:KURN)

Switzerland · Delayed Price · Currency is CHF

21.60

+1.30 (6.40%)

Oct 26, 2026, 11:34 AM CET

Kuros Biosciences AG Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	174.93	146.06	85.16	39.86	19.45	15.15
Revenue Growth	19.77%	71.51%	113.65%	104.92%	28.35%	231.96%
Gross Profit	154.34	127.45	75.67	33.81	15.54	11.04
Operating Income	10.62	8.95	0.12	-6.04	-10.65	-9.62
Net Income	8.97	2.55	-4.84	-16.3	-15.78	-8.27
Earnings Per Share	0.22	0.06	-0.13	-0.45	-0.47	-0.25
EPS Growth	250.42%	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States of America	170.09	140.94	82.1	39	18.8	14.5
European Union	3.65	3.11	0.84	0.69	0.46	0.31
Other	1.19	2.01	2.22	0.17	0.19	0.35
Total	174.93	146.06	85.16	39.86	19.45	15.15

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	9.73	19.77	19.76	16.87	26.03	31.4
Total Debt	10.07	1.39	1.97	2.54	2.07	2.43
Net Cash (Debt)	-0.33	18.38	17.8	14.33	23.96	28.97
Net Cash Growth	-	3.28%	24.20%	-40.19%	-17.31%	-1.34%
Net Cash Per Share	-0.01	0.44	0.48	0.39	0.71	0.88

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-0.62	-0.46	3.54	-10.5	-7.95	-5.99
Capital Expenditures	-8.09	-2.44	-1.23	-0.38	-0.43	-0.33
Free Cash Flow	-8.72	-2.89	2.31	-10.88	-8.37	-6.32
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	88.23%	87.26%	88.85%	84.83%	79.89%	72.86%
Operating Margin	6.07%	6.13%	0.14%	-15.15%	-54.74%	-63.46%
Pretax Margin	6.15%	3.43%	-4.43%	-29.13%	-88.91%	-69.16%
Profit Margin	5.13%	1.75%	-5.68%	-40.90%	-81.15%	-54.59%
FCF Margin	-4.98%	-1.98%	2.71%	-27.29%	-43.05%	-41.72%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	122.75	531.92	-	-	-	-
Forward PE	56.18	80.23	-	-	-	-
P/FCF Ratio	-	-	385.54	-	-	-
PS Ratio	5.71	9.29	10.44	3.82	2.99	4.57